{"id":3774,"date":"2023-09-30T09:41:00","date_gmt":"2023-09-30T16:41:00","guid":{"rendered":"https:\/\/www.staging.gigamune.com\/?p=3774"},"modified":"2023-12-04T09:44:44","modified_gmt":"2023-12-04T17:44:44","slug":"gigamune-wins-its-seventh-sbir-grant","status":"publish","type":"post","link":"https:\/\/www.staging.gigamune.com\/?p=3774","title":{"rendered":"GigaMune wins its seventh SBIR grant"},"content":{"rendered":"\n<p>GigaMune won its seventh SBIR grant, entitled &#8220;Delivery of Full Length Dystrophin to Muscle Cells for DMD Gene Therapy&#8221; from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The project seeks to expand the capabilities of GigaMune&#8217;s technology into delivery of curative transgenes to muscle cells. GigaMune&#8217;s Founder and CEO Dr. David Johnson is principal investigator (PI) on the project. This is Dr. Johnson&#8217;s nineteenth SBIR grant as PI.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>GigaMune won its seventh SBIR grant, entitled &#8220;Delivery of Full Length Dystrophin to Muscle Cells for DMD Gene Therapy&#8221; from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The project seeks to expand the capabilities of GigaMune&#8217;s technology into delivery of curative transgenes to muscle cells. GigaMune&#8217;s Founder and CEO Dr. David [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3881,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"image","meta":{"footnotes":""},"categories":[4],"tags":[],"_links":{"self":[{"href":"https:\/\/www.staging.gigamune.com\/index.php?rest_route=\/wp\/v2\/posts\/3774"}],"collection":[{"href":"https:\/\/www.staging.gigamune.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.staging.gigamune.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.staging.gigamune.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.staging.gigamune.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3774"}],"version-history":[{"count":1,"href":"https:\/\/www.staging.gigamune.com\/index.php?rest_route=\/wp\/v2\/posts\/3774\/revisions"}],"predecessor-version":[{"id":3775,"href":"https:\/\/www.staging.gigamune.com\/index.php?rest_route=\/wp\/v2\/posts\/3774\/revisions\/3775"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.staging.gigamune.com\/index.php?rest_route=\/wp\/v2\/media\/3881"}],"wp:attachment":[{"href":"https:\/\/www.staging.gigamune.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3774"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.staging.gigamune.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3774"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.staging.gigamune.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3774"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}